Wuhan Greenon Biotechnology

About Wuhan Greenon Biotechnology

Wuhan Greenon Biotechnology operates as a biomanufacturing platform centered on bacteriophage technology. The company directs its research and development efforts toward creating solutions across four principal sectors. For the aquaculture industry, it aims to reduce the reliance on antibiotics to improve farming efficiency. In agriculture, the focus is on precise biocontrol of plant diseases to ensure the safety of produce. The company also works on pathogen biocontrol systems for the food industry, covering the chain from farm to consumer. Lastly, it is developing new applications for oral and skin microbiome management within the biomedical field.

Established in Wuhan, China, the company has built a significant intellectual property portfolio, with more than 90 patent applications, of which over 60 are for inventions. A key strategic element is its deep collaboration with Huazhong Agricultural University, which facilitates joint research on advanced technologies. Through these collaborations, Wuhan Greenon Biotechnology has developed extensive bacteriophage and host bacteria libraries, which support its product development and provide a resource for the broader scientific community. The business model is structured around a complete industry chain, encompassing research, production, and application to serve its target markets.

The company's stated mission is to drive the global application of bacteriophage technology. It positions itself as a key contributor to ecological safety and human health through its specialized biological solutions.